Abstract 1302: Venous Sinus Stenting Versus Cerebrospinal Fluid Diversion for Idiopathic Intracranial Hypertension
Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)
DOI: 10.1161/svi270000_1302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von M. Elfil und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Importance: Venous sinus stenting (VSS) has emerged as a targeted alternative to cerebrospinal fluid (CSF) diversion for medically refractory idiopathic intracranial hypertension (IIH), yet comparative evidence remains limited, and no randomized controlled trial has been completed.
Objective
To synthesize comparative evidence on the efficacy, safety, and cost of VSS versus CSF diversion and medical management in patients with IIH. Data Sources: PubMed, Web of Science, Scopus, Embase, ProQuest, and EBSCO were searched from inception through March 2026, supplemented by backward citation analysis. Study Selection: Comparative studies enrolling IIH patients who underwent VSS versus at least one active comparator, including CSF diversion procedures, optic nerve sheath fenestration (ONSF), or medical management, were eligible. Data Extraction and Synthesis: This study was conducted in accordance with the PRISMA guidelines. Two independent reviewers extracted data and assessed risk of bias using ROBINS-I Version 2. Random-effects meta-analysis was performed using RStudio and RevMan 5.4. Main Outcomes and Measures: Primary outcomes were headache recurrence and papilledema resolution. Secondary outcomes included treatment failure, Frisén grade change, pulsatile tinnitus, acetazolamide-dose reduction, and hospitalization costs.
Results
Eleven studies with a total of 9,274 patients were included. Compared with medical management, VSS was associated with significantly greater symptom improvement post-intervention (risk ratio [RR] 4.86; 95% CI, 1.47-16.05) and at 6 months (RR 3.21; 95% CI, 1.96-5.24). Compared with CSF diversion, VSS demonstrated significantly lower headache recurrence (RR 0.47; 95% CI, 0.29-0.75), residual headache (RR 0.65; 95% CI, 0.51-0.82), and papilledema persistence (RR 0.85; 95% CI, 0.74-0.97). No significant difference was observed in overall treatment failure (RR 0.60; 95% CI, 0.27-1.32), Frisén grade change, or acetazolamide dose reduction. VSS was associated with higher initial hospitalization costs (mean difference $3,411.59; 95% CI, $531.81-$6,291.36). All 11 studies were observational, and the risk of bias was serious in 7 and critical in 4.
Conclusions
In this study, VSS demonstrated significantly better headache and papilledema outcomes than CSF diversion and substantially superior symptom improvement over medical management, supporting its potential role as an effective alternative for appropriately selected patients with medically refractory IIH. However, a well-designed narrow prospective randomized trial might still be needed.
Zitieren
APA
Elfil, M., Hawas, Y., Soldozy, S., Elmashad, A., Sabet, H., Albanna, A. J., Najdawi, Z., Pervez, M., Elsayed, S., Kaur, G., Abdalkader, M. K., Patsalides, A., Gandhi, C. D., & Al-Mufti, F. (2026). Abstract 1302: Venous Sinus Stenting Versus Cerebrospinal Fluid Diversion for Idiopathic Intracranial Hypertension. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_1302
Vancouver
Elfil M, Hawas Y, Soldozy S, Elmashad A, Sabet H, Albanna AJ, et al. Abstract 1302: Venous Sinus Stenting Versus Cerebrospinal Fluid Diversion for Idiopathic Intracranial Hypertension. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_1302
BibTeX
@article{Elfil2026,
author = {Elfil, M. and Hawas, Y. and Soldozy, S. and Elmashad, A. and Sabet, H. and Albanna, A. J. and Najdawi, Z. and Pervez, M. and Elsayed, S. and Kaur, G. and Abdalkader, M. K. and Patsalides, A. and Gandhi, C. D. and Al-Mufti, F.},
title = {Abstract 1302: Venous Sinus Stenting Versus Cerebrospinal Fluid Diversion for Idiopathic Intracranial Hypertension},
journal = {Stroke: Vascular and Interventional Neurology},
year = {2026},
volume = {6},
number = {Suppl_1},
doi = {10.1161/svi270000_1302}
}
EUVIMED